This result is discussed in relation to in vivo substrate limitations.
Introduction
The studies reported here concern the relative importance of the acyl dihydroxyacetone phosphate and sn-glycerol 3-phosphate pathways in the de novo synthesis of glycerolipids. These pathways are illustrated in Fig. 1 .
The following is known about the acyl dihydroxyacetone phosphate pathway: (1) several tissues can acylate dihydroxyacetone phosphate with long- chain acyl CoAs [l] ; (2) acyl dihydroxyacetone phosphate is a direct precursor of ether glycerolipids [2] ; (3) subcellular fractions of several tissues can reduce acyl dihydroxyacetone phosphate with NADPH to form 1-acyl-sn-glycerol 3-phosphate [3] ; (4) acyl glycerol phosphate is a direct precursor of phosphatidic acid and thus of glycerolipids in general [4] ; (5) since tissues are potentially able to acylate dihydroxyacetone phosphate, then reduce acyl dihydroxyacetone phosphate, an alternate pathway to acyl glycerol phosphate and thus to glycerolipids is possible [ 
51.
The glycerol phosphate pathway for phosphatidic acid synthesis consists of the NADH-dependent reduction of dihydroxyacetone phosphate by glycerol phosphate dehydrogenase (EC 1.1.1.8), then acylation by glycerol phosphate : acyl CoA acyltransferase (EC 2.3.1.15). The activity of glycerol phosphate dehydrogenase, the first step in the glycerol phosphate pathway, differs greatly among tissues, and it is especially low in tumors [6] . This diversity suggests that the relative importance of the two pathways in phosphatidic acid synthesis may also differ, depending on the activity of glycerol phosphate dehydrogenase. In Morris hepatomas, the concentration of ether glycerolipids increases with decreasing activity of glycerol phosphate dehydrogenase [7] . Since ether glycerolipids are produced from acyl dihydroxyacetone phosphate, this finding suggests the relative carbon flow through the acyl dihydroxyacetone phosphate pathway might also increase as the glycerol phosphate dehydrogenase activity decreases. We have previously provided evidence that one tumor, Ehrlich ascites, uses the acyl dihydroxyacetone phosphate pathway relatively more than a normal tissue, liver, which has a higher activity of glycerol phosphate dehydrogenase [ 2, 8] . The present study examines the relative utilization of the glycerol phosphate and acyl dihydroxyacetone phosphate pathways in de novo synthesis of glycerolipids. We chose tissues in which glycerol phosphate dehydrogenase activity is expected to be low, such as tumors, so that a greater dependence on the acyl dihydroxyacetone phosphate pathway might be anticipated. A preliminary report of this work has been published [9] .
Materials and Methods

Tissues
Transformed and normal astroglia were kindly provided by H.M. Shein. Nitrosourea-transformed rat astroglia, lines C-6 and C-2, , were prepared by multiple intravenous injections of N-nitrosomethylurea [lo] . Line C-6 is differentiated (Grades I and II), while line C-21 is pleomorphic (Grade III) [lo] . Normal astroglia were prepared from newborn Syrian hamsters by culturing dispersed brain fragments for 14 days [ 111. Neurons and oligodendroglia do not survive this culture period [ 111. Astroglia transformed by SV-40 were derived from astroglial cultures of either fetal (2/3 gestational) or newborn hamsters, lines THA 15 and NT 1, respectively [12] . The transformed astroglia from fetal hamsters are poorly differentiated (Grade IV), and those from newborn hamsters are a mixture of well-and poorly differentiated cells [ 121. These various tissues were stored at -70°C for two years before being used.
Neuroblastoma Cl300 was donated by R.W. Ruddon. This tumor was grown subcutaneously in A/J mice.
The line Ii, leukemia cells were contributed by W.H. Murphy. They were prepared from the spleens of leukemic C58/wm mice [13] .
Leukocytes were isolated from crushed spleens of normal C58 mice. After the reticular material settled, the supernatant extract was centrifuged twice for 2 min at 50 X g to collect the leukocytes. Blood lymphocytes were isolated from fresh human peripheral blood [ 141. We prepared thymocytes from thymus glands by grinding minced glands from male Spraque-Dawley rats in KrebsRingers phosphate buffer [15] with a Dual1 tissue grinder, then sedimenting reticular material by a 3 min centrifugation at 100 X g. The supernatant was then used without further purification. The lymphocytes and thymocytes were identified after treatment with Wright's strain [ 161.
Mouse brain and liver were taken from male Swiss mice. The fetal brain sample (12 brains) was prepared from a pregnant Spraque-Dawley rat. The average fetus body and brain weighed 4.8 and 0.19 g, respectively.
Is0 topes D -[ 1-3 H] Glucose and carrier-free 3 2 Pi were purchased from New England Nuclear.
[Y-~~P] ATP WEIS synthesized by a Pi : ATP exchange reaction [17] . To produce dihydroxyacetone [ The incubation mixture was prewarmed 4 min at 37°C then the reaction started by the addition of homogenate. Unless otherwise stated, we terminated the incubations after an additional 4 min at 37°C by adding 4.5 ml of chloroform/methanol (1 : 2). The lipids were then extracted under acidic conditions [3] in order to completely extract acyl glycerol phosphate and acyl dihydroxyacetone phosphate [24] . We isolated the phosphatidic acid by thin-layer chromatography with the solvent chloroform/methanol/acetic acid/5% freshly-made aqueous busulfite (100 : 40 : 12 : 4, by vol.) [3, 5] . The lipids were located by autoradiography and scraped from the plate. Before being counted, the scrapings were dispersed by sonication in a mixture of 0.6 ml of water and 10 ml of toluene-based scintillant containing 26% (by vol.) Triton X-100.
To we used the dihydroxyacetone phosphatedependent oxidation of NADH [25] . The rate of NADH-oxidation that existed in the absence of dihydroxyacetone phosphate is subtracted.
Results
Assay conditions
In order to find suitable conditions for assaying the pathways for the tissue survey, we examined the effect of several assay variables. These include the dependence of phosphatidic acid synthesis upon the concentration of homogenate protein, the incubation period, the substrate concentration, the method for providing acyl CoA and the storage history of the tissue.
The formation of phosphatidic acid from either dihydroxyacetone phosphate or glycerol phosphate is roughly proportional to the amount of homogenate protein present ( Fig. 2) , which demonstrates that the assay system adequately measures enzyme concentration.
There may be slightly less than the expected rate of phosphatidic acid synthesis from dihydroxyacetone phosphate via the glycerol phosphate pathway when small amounts of homogenate pro- Fig. 3d . An incubation period of 4 min was used for further studies. The effect of dihydroxyacetone phosphate concentration on the rates of incorporation into phosphatidic acid via glycerol phosphate and acyl dihydroxyacetone phosphate is shown in Fig. 4 . The apparent K, for dihydroxyacetone phosphate is the same for the two pathways in brain homogenate. This suggests that the relative rates of dihydroxyacetone phosphate incorporation into phosphatidic acid via the two pathways should not depend on the dihydroxyacetone phosphate concentration. A dihydroxyacetone phosphate concentration of 1 mM was chosen for subsequent assays. Also shown in Fig. 4 is the dependence of phosphatidic acid synthesis on glycerol phosphate concentration. The K, values for glycerol precursors are relatively large, about 0.5 mM and 0.8 mM for dihydroxyacetone phosphate and glycerol phosphate, respectively. This indicates that, for the glycerol phosphate pathway, the rate of the glycerol phosphate : acyl CoA acyltransferase step might increase with time as glycerol phosphate, formed from dihydroxyacetone phosphate, accumulates. The data of Fig. 3 suggests this is not very significant. A steady state for the glycerol phosphate pathway is apparently attained within 2-4 min.
The linear dependence of phosphatidic acid synthesis upon both protein concentration (Fig. 2 ) and incubation period (Fig. 3) implies that none of the substrates are depleted. To confirm this, we determined the substrate concentrations at the end of the brain and liver assays (Table I) . Except for NADH in the liver assay, the substrates were not depleted. In both the brain and liver Glycerol phosphate dehydrogenase is probably fully active under the conditions used for assaying lipid synthesis, since the amount of glycerol phosphate formed from dihydroxyacetone phosphate plus NADH is about that expected from the measured glycerol phosphate dehydrogenase activity of brain and liver (See Table V ). As expected, no glycerol phosphate was formed when NADH was replaced by NADPH.
The procedure chosen for assaying the various lipid-synthesizing activities uses endogenous fatty acid thiokinase (EC 6.2.1.3) to generate acyl CoA. To check whether the relative rates of the two pathways reflect the method for providing acyl CoA, the rates of dihydroxyacetone phosphate : acyl CoA and Tables IV and V , confirms that the fatty acid thiokinase step is not seriously rate-limiting for the glycerol phosphate pathway under our assay conditions. The brain tumors and cultured glial cells were stored about two years at -70°C before use. To test the possibility' that some of the enzymes had denatured during storage, we assayed fresh neuroblastoma and reassayed additional samples after storage at -70°C (Table III) . The stability of this tissue to storage suggests that the other stored tissue samples were not significantly denatured. We also measured the lactate dehydrogenase (EC 1.1.1.27) activities of these stored tissues to determine whether their low glycerol phosphate dehydrogenase activities reflect extensive denaturation of soluble enzymes, in general. Although the glycerol phosphate dehydrogenase activities of the stored tissues were usually lower (See Table V) , their lactate dehydrogenase activities were higher than that of fresh mouse brain.
Tissue survey
A summary of the glycerol phosphate and acyl dihydroxyacetone phosphate pathway activities found with a variety of tissue homogenates is shown in Table IV . The relative ability of these tissues to form phosphatidic acid from dihydroxyacetone phosphate via acyl dihydroxyacetone phosphate is greater than via glycerol phosphate.
Although the rates of both pathways tend to decrease together, the differences between pathway ratios are mainly due to changes in the rate of the glycerol phosphate pathway. Thus, the tissue homogenates that showed a high pathway ratio had a low rate of phosphatidate synthesis via glycerol phosphate rather than a high rate of synthesis via acyl dihydroxyacetone phosphate. The two methods for measuring the acyl dihydroxyacetone phosphate --__.
--- The rates of the separate enzyme steps in the two pathways are summarized in Table V . As indicated by previous work 133, the rate-limiting step in the acyl dihydroxyacetone phosphate pathway is dihydroxyacetone phosphate : acyl CoA acyltransferase.
As either glycerol phosphate : acyl CoA acyltransferase or glycerol phosphate dehydrogenase increases, the rate of the glycerol phosphate pathway also increases (Fig. 5) . Thus, these two steps act rate-limiting to the glycerol phosphate pathway. Since their individual rates are each much greater than the measured rate of the glycerol phosphate pathway, this is unexpected.
Table V also shows that the enzymes of the glycerol phosphate pathway are more active than those of the acyl dihydroxyacetone phosphate pathway. Thus the data in Table V imply a much more active glycerol phosphate than acyl dihydroxyacetone phosphate pathway, whereas the data in Table IV support the opposite conclusion.
Discussion
The purpose of this study is to help answer the question: do tissues differ in their dependence on acyl dihydroxyacetone phosphate for synthesizing glycerolipids? The data in Table IV showing the highest pathway ratios were those of normal tissues. The effect of transformation upon the pathway ratio was not rigorously examined, however.
Tissue homogenates differ in their dependence on the acyl dihydroxyacetone phosphate pathway, but these differences are primarily due to changes in the rate of the glycerol phosphate pathway. The measured activities of the acyl dihydroxyacetone phosphate pathway do not increase as those of the glycerol phosphate pathway decrease. Thus, those tissues which show little glycerol phosphate pathway activity should have a decreased ability to synthesize glycerolipids.
As suggested by previous work [7, 8] , the apparent utilization by a tissue of the acyl dihydroxyacetone phosphate pathway is greater for those tissues with little glycerol phosphate dehydrogenase.
The relative rates of dihydroxyacetone phosphate incorporation via the two pathways (Table IV) are difficult to reconcile with the observed activities of the separate steps (Table V) . The measured enzyme activities of limiting steps in the glycerol phosphate pathway are several fold higher than the limiting step in the acyl dihydroxyacetone phosphate pathway. The way in which the pathways are compared (Table IV) offers one possible explanation for this discrepancy. Our choice of dihydroxyacetone phosphate as the precursor and use of a short incubation period may bias the estimate of the pathways in favor of the acyl dihydroxyacetone phosphate pathway. We have previously reported that the use of dihydroxyacetone phosphate as the precursor gives a higher acyl dihydroxyacetone phosphate/glycerol phosphate pathway ratio than does the use of fructose 1,6-diphosphate or glucose [8] . With dihydroxyacetone phosphate as the precursor, dihydroxyacetone phosphate : acyl CoA acyltransferase is exposed to a high dihydroxyacetone phosphate concentration from the start of the incubation but glycerol phosphate : acyl CoA acyltransferase is exposed to no glycerol phosphate. As the incubation proceeds, the glycerol phosphate concentration increases and the rate of the glycerol phosphate pathway should increase. For example, the expected rate of the glycerol phosphate pathway in thymocyte homogenate can be calculated from the measured rates of glycerol phosphate dehydrogenase and glycerol phosphate : acyl CoA acyltransferase in the homogenate and the K, for glycerol phosphate of glycerol phosphate : acyl CoA acyltransferase seen in brain homogenate (Fig. 4) . However, the observed rate of the glycerol phosphate pathway (Fig. 3c) fails to increase. The observed rate is ten-fold less than the calculated rate after ten min of incubation.
A second possible explanation for the discrepancy between the measured pathway ratio (Table IV) and the activity of the pathway enzymes (Table V) is that we are misinterpreting the measured glycerol phosphate dehydrogenase activity. Perhaps only a fraction of the total enzyme is active in glycerolipid synthesis. It has been reported [30] that a significant percentage (20-60%) of the total glycerol phosphate dehydrogenase in liver and kidney may be peroxisomal and therefore, presumably, not used for glycerolipid synthesis. Also, there is evidence that much of the liver glycerol phosphate dehydrogenase may be used in catabolism rather than in glycerolipid synthesis [31] . Finally, a membrane-bound glycerol phosphate dehydrogenase has been observed but its function is unknown [ 3,301. It is reported that the physiolo~c~ glycerol phosphate concentration is much greater than the dihydroxyacetone phosphate concentration. In liver and brain, the glycerol phosphate/dihydroxyacetone phosphate ratio is about ten [32, 33] . Even in cells with very little glycerol phosphate dehydrogenase activity, such as Ehrlich ascites, the glycerol phosphate/dihydroxyacetone phosphate ratio is also reported to be about ten 1341. In addition, the glycerol phosphate concen~ation in a mamma gland tumor is as great as that in normal gland, yet the former has much less glycerol phosphate dehydrogenase [35] . Given the greater activity of glycerol phosphate acyltransferase than dihydroxyacetone phosphate acyltransferase in the tissues used (Table V) and a glycerol phosphate concentration greater than dihydroxyacetone phosphate, it remains probable that in vivo the glycerol phosphate pathway to glycerolipids is more active than the acyl dihydroxyacetone phosphate pathway. On the other hand, two observations are consistent with a significant contribution by the acyl dihydroxyacetone phosphate pathway to glycerolipid synthesis. First, most reductive, synthetic pathways use NADPH rather than NADH [36] . The lo5 -fold higher ratio of NADPHINADP than NADH/NAD facilitates synthesis using NADPH [ 371 f The acyl dihydroxyacetone phosphate pathway fits this generalization, but the glycerol phosphate pathway does not. Second, an assay of the glycerol phosphate pathway in liver slices implied that about one-half of the glycerolipid is synthesized from acyl dihydroxyacetone phosphate [38] . This assay uses glycerol and, thus, it does not include the normal branch point of the metabolic sequence (Fig. 1) . Glucose is the usual glyceride glycerol precursor [3!3] , and its conversion to glycerol phosphate is subject to possible regulation by the intracellular NADH/NAD ratio. Thus, the acyl dihydroxyacetone phosphate pathway in the liver in vivo could be even more active than that reported.
We 
